Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q8NHP6

Entry ID Method Resolution Chain Position Source
6TQS X-ray 225 A A/B/C/D/E/F 282-490 PDB
6TQT X-ray 150 A A 282-490 PDB
6TQU X-ray 240 A A/B 315-445 PDB
AF-Q8NHP6-F1 Predicted AlphaFoldDB

213 variants for Q8NHP6

Variant ID(s) Position Change Description Diseaes Association Provenance
TCGA novel 1 M>? Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 3 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA412445528
rs1158167728
3 E>Q No ClinGen
gnomAD
CA412445549
rs1471203802
4 N>Y No ClinGen
gnomAD
rs780598216
CA10353270
5 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1424800473
CA412445564
6 A>S No ClinGen
gnomAD
CA412445572
rs1468399379
7 Q>R No ClinGen
gnomAD
rs1221540390
CA412445580
8 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs747306358
CA10353271
11 K>N No ClinGen
ExAC
gnomAD
CA412445598
rs1174053875
11 K>Q No ClinGen
gnomAD
rs1322759303
CA412445603
11 K>R No ClinGen
TOPMed
rs1288703409
CA412445622
14 S>C No ClinGen
TOPMed
CA10353272
rs769255922
22 A>T No ClinGen
ExAC
gnomAD
CA412445678
rs1328105316
23 E>K No ClinGen
gnomAD
rs747760686
CA10353274
26 T>P No ClinGen
ExAC
gnomAD
rs755293601
CA10353289
28 K>E No ClinGen
ExAC
gnomAD
CA10353291
rs375563130
34 A>G No ClinGen
ESP
ExAC
gnomAD
rs375563130
CA10353292
34 A>V No ClinGen
ESP
ExAC
gnomAD
CA10353293
COSM1116741
rs145214899
35 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs748763207
CA10353294
35 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA10353295
rs147627753
42 Q>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA327065636
rs3174450
45 N>K No ClinGen
Ensembl
rs1292225834
CA412435321
45 N>S No ClinGen
TOPMed
rs1436222825
CA412435333
47 V>I No ClinGen
TOPMed
CA412435344
rs1318305263
48 E>G No ClinGen
gnomAD
CA412435351
rs1355537127
49 S>T No ClinGen
TOPMed
CA412435377
rs1436651521
53 W>G No ClinGen
Ensembl
CA412435387
rs1477616051
54 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA10353296
rs773858437
55 H>Y No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 62 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA412435454
rs1428106435
63 K>N No ClinGen
TOPMed
CA327065637
rs907801894
64 M>I No ClinGen
gnomAD
TCGA novel 65 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353298
rs771780826
66 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs775308720
CA10353299
67 E>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA327065638
rs142229431
75 I>M No ClinGen
ESP
TCGA novel 75 I>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs371878524
CA10353301
76 S>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756650603
CA10353309
81 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs146163894
CA327065794
91 E>K No ClinGen
ESP
TOPMed
gnomAD
rs1396043047
CA412435742
92 I>M No ClinGen
TOPMed
CA412435770
rs1442700764
95 I>N No ClinGen
TOPMed
gnomAD
rs770339586
CA10353312
97 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA10353313
rs746588950
98 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs1383182994
CA412435862
103 E>A No ClinGen
gnomAD
CA327065796
rs371329982
106 K>N No ClinGen
Ensembl
TCGA novel 107 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 109 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353326
rs753107625
111 R>G No ClinGen
ExAC
gnomAD
CA412436319
rs1176223996
113 K>E No ClinGen
gnomAD
TCGA novel 117 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA327065899
rs930032726
122 I>L No ClinGen
Ensembl
CA327065900
rs1056458554
122 I>T No ClinGen
Ensembl
CA412436494
rs1337969791
125 K>T No ClinGen
gnomAD
rs778315491
CA10353328
129 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA327065901
rs896668101
130 A>T No ClinGen
Ensembl
rs908131981
CA327065902
130 A>V No ClinGen
TOPMed
gnomAD
rs1333522487
CA412436568
132 W>R No ClinGen
TOPMed
CA10353329
rs754359723
136 Y>F No ClinGen
ExAC
TOPMed
gnomAD
CA10353330
rs373192139
144 P>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10353331
rs778320150
144 P>L No ClinGen
ExAC
gnomAD
CA412436694
rs1331575756
145 V>L No ClinGen
gnomAD
CA10353332
rs745355830
154 T>S No ClinGen
ExAC
rs1468508961
CA412436781
158 S>G No ClinGen
TOPMed
CA412436787
rs1277502925
158 S>R No ClinGen
gnomAD
rs767688089
CA10353343
165 R>C No ClinGen
ExAC
gnomAD
rs1263277769
CA412437033
165 R>H No ClinGen
TOPMed
CA10353344
rs775680398
168 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1281625900
CA412437117
172 K>N No ClinGen
gnomAD
rs774292970
CA327066248
181 K>N No ClinGen
TOPMed
CA10353361
rs769665676
183 V>L No ClinGen
ExAC
gnomAD
TCGA novel 184 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1018809258
CA327066249
185 F>S No ClinGen
Ensembl
TCGA novel 186 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353362
rs184946599
187 M>T No ClinGen
1000Genomes
ExAC
TOPMed
TCGA novel 188 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353364
rs772139976
192 N>S No ClinGen
ExAC
gnomAD
rs1233375767
CA412437434
193 A>T No ClinGen
TOPMed
rs1485103067
CA412438094
196 K>R No ClinGen
gnomAD
CA10353371
rs765732670
201 W>C No ClinGen
ExAC
gnomAD
rs999972979
CA327066642
202 L>F No ClinGen
Ensembl
rs758774781
CA10353373
214 S>R No ClinGen
ExAC
gnomAD
CA412438313
rs1602037662
216 N>D No ClinGen
Ensembl
rs766009045
CA10353374
216 N>K No ClinGen
ExAC
gnomAD
TCGA novel 217 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 219 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754716748
CA10353376
220 D>A No ClinGen
ExAC
gnomAD
rs1343605272
CA412438400
223 S>I No ClinGen
TOPMed
gnomAD
rs1343605272
CA412438398
223 S>N No ClinGen
TOPMed
gnomAD
rs752489544
CA10353378
223 S>R No ClinGen
ExAC
gnomAD
CA327066660
rs143673501
226 Y>H No ClinGen
ESP
gnomAD
CA412438454
rs1258882715
228 P>L No ClinGen
TOPMed
CA10353380
rs777360876
230 H>N No ClinGen
ExAC
gnomAD
CA10353381
rs746053684
232 G>S No ClinGen
1000Genomes
ExAC
gnomAD
rs370427075
CA327066662
234 T>N No ClinGen
Ensembl
CA327066830
rs975603419
236 P>S No ClinGen
Ensembl
TCGA novel 237 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs35164803
VAR_034109
CA10353393
240 S>N No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 240 S>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353395
rs752396113
245 V>A No ClinGen
ExAC
TOPMed
gnomAD
CA327066831
rs370959017
245 V>I No ClinGen
ESP
TOPMed
CA412438726
rs370959017
245 V>L No ClinGen
ESP
TOPMed
rs1275723913
CA412438805
251 T>S No ClinGen
gnomAD
rs1569106135
CA412438882
258 P>R No ClinGen
Ensembl
rs1370802848
CA412438885
259 I>V No ClinGen
gnomAD
CA412438918
rs777657462
262 E>K No ClinGen
ExAC
gnomAD
CA10353397
rs777657462
262 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 271 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772728487
CA327066832
272 E>A No ClinGen
Ensembl
rs1323315172
CA412439054
273 S>C No ClinGen
TOPMed
gnomAD
rs1323315172
CA412439053
273 S>G No ClinGen
TOPMed
gnomAD
TCGA novel 277 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1443465490
CA412439130
279 L>S No ClinGen
gnomAD
CA412439135
rs1385341760
280 E>K No ClinGen
TOPMed
rs757238717
CA10353399
287 Q>K No ClinGen
ExAC
gnomAD
rs377500177
CA412439236
288 T>I No ClinGen
gnomAD
CA327066833
rs377500177
288 T>K No ClinGen
gnomAD
rs778812199
CA10353400
289 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1439661540
CA412439893
COSM1116744
298 E>K Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA10353414
rs760049672
299 S>P No ClinGen
ExAC
gnomAD
rs760049672
CA10353413
299 S>T No ClinGen
ExAC
gnomAD
rs1382386431
CA412439962
303 A>E No ClinGen
TOPMed
rs752096955
CA10353415
303 A>T No ClinGen
ExAC
gnomAD
rs1602039826
CA412439995
305 E>D No ClinGen
Ensembl
CA412440013
rs1373265166
307 E>K No ClinGen
TOPMed
gnomAD
TCGA novel 310 D>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1478195809
CA412440079
311 S>L No ClinGen
gnomAD
TCGA novel 313 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs905836720
CA327066867
315 A>S No ClinGen
TOPMed
rs145104885
CA327066868
319 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs145104885
CA10353419
319 P>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs982032203
CA327066869
321 S>N No ClinGen
Ensembl
CA10353421
rs368007476
322 V>L No ClinGen
ESP
ExAC
gnomAD
TCGA novel 325 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758285034
CA10353422
329 H>Y No ClinGen
ExAC
gnomAD
rs867674887
CA327066982
332 P>Q No ClinGen
Ensembl
CA10353435
rs41297321
340 S>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10353434
rs41297321
340 S>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs199908168
CA327066983
341 T>A No ClinGen
Ensembl
CA10353437
rs765041573
344 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1164665484
CA412440646
348 T>I No ClinGen
gnomAD
CA10353438
rs750180336
351 V>L No ClinGen
ExAC
gnomAD
rs369620205
CA327067060
366 T>I No ClinGen
ESP
TOPMed
TCGA novel 378 N>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 381 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1172864310
CA412440981
382 D>G No ClinGen
gnomAD
rs766405868
CA10353461
383 P>L No ClinGen
ExAC
gnomAD
CA412440989
rs766405868
383 P>R No ClinGen
ExAC
gnomAD
CA327067062
rs1050358567
384 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1393417509
CA412440991
384 G>R No ClinGen
TOPMed
CA412441104
rs1413654251
400 S>P No ClinGen
gnomAD
CA327067078
rs968134247
401 A>V No ClinGen
Ensembl
TCGA novel 403 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs373087009
CA10353471
404 R>C No ClinGen
ESP
ExAC
gnomAD
CA412441134
rs1176124863
404 R>H No ClinGen
gnomAD
rs769168126
CA10353472
407 I>V No ClinGen
ExAC
gnomAD
CA10353473
rs780722199
408 M>I No ClinGen
ExAC
rs1468017402
CA412441177
410 A>T No ClinGen
TOPMed
gnomAD
rs747633106
CA10353474
412 M>I No ClinGen
ExAC
gnomAD
CA412441201
rs1287188596
412 M>V No ClinGen
TOPMed
rs1395867508
CA412441210
413 E>K No ClinGen
gnomAD
CA412441226
rs1389701540
415 S>A No ClinGen
gnomAD
CA10353475
rs769492399
415 S>L No ClinGen
ExAC
gnomAD
CA412441224
rs1389701540
415 S>T No ClinGen
gnomAD
rs772846336
CA10353476
416 S>C No ClinGen
ExAC
gnomAD
CA10353477
rs762599533
417 G>A No ClinGen
ExAC
gnomAD
rs762599533
CA412441238
417 G>V No ClinGen
ExAC
gnomAD
CA327067079
rs142203054
418 T>I No ClinGen
ESP
TOPMed
gnomAD
CA10353478
rs764071636
420 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA412441277
rs1212160046
424 T>A No ClinGen
gnomAD
CA327067080
rs935104308
424 T>I No ClinGen
Ensembl
CA412441329
rs1256477922
431 P>A No ClinGen
gnomAD
CA10353479
rs376188992
432 R>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA10353481
rs767527870
433 N>K No ClinGen
ExAC
gnomAD
rs759420459
CA10353480
433 N>S No ClinGen
ExAC
gnomAD
rs1472712274
CA412441368
436 M>I No ClinGen
gnomAD
CA412441381
rs1199218234
438 H>R No ClinGen
gnomAD
rs145446651
CA327067081
438 H>Y No ClinGen
1000Genomes
TOPMed
gnomAD
CA10353496
rs777872789
443 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA10353495
rs777203055
443 H>Y No ClinGen
ExAC
gnomAD
CA10353497
rs11797118
444 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs759364943
CA10353499
449 K>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA412441476
rs1261685821
450 P>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1192115262
CA412441475
450 P>S No ClinGen
gnomAD
TCGA novel 453 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA412441502
rs772206668
454 T>K No ClinGen
ExAC
gnomAD
CA10353500
rs772206668
454 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA412441503
rs772206668
454 T>R No ClinGen
ExAC
gnomAD
CA412441525
CA327067229
rs979142049
457 D>E No ClinGen
gnomAD
CA10353502
rs771081569
458 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1287374803
CA412441611
469 D>G No ClinGen
TOPMed
CA327067230
rs956150373
469 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1356878782
CA412441620
470 I>M No ClinGen
TOPMed
CA10353503
rs765430843
470 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1569107911
CA412441661
475 S>C No ClinGen
Ensembl
CA10353516
rs745450327
476 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA412441694
rs1434743046
480 S>C No ClinGen
gnomAD
rs1344390933
COSM1743803
CA412441705
481 N>S biliary_tract [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
TCGA novel 482 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA327067287
rs906678814
490 R>C No ClinGen
TOPMed
CA10353518
rs186948760
490 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs768684561
COSM3701811
CA10353520
492 I>V liver [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA412441789
rs1281917140
493 W>R No ClinGen
gnomAD
CA412441808
rs1380960859
494 F>L No ClinGen
gnomAD
CA10353521
rs760339015
494 F>S No ClinGen
1000Genomes
ExAC
gnomAD
CA10353522
rs149352938
497 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs753032101
CA10353523
503 M>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 504 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10353524
rs774637512
505 L>F No ClinGen
ExAC
gnomAD
rs759696962
CA10353525
511 S>C No ClinGen
ExAC
gnomAD
CA412442028
rs1208182877
511 S>P No ClinGen
gnomAD
rs905695161
CA327067288
513 F>V No ClinGen
Ensembl
rs1473128001
CA412442070
514 Y>N No ClinGen
gnomAD

No associated diseases with Q8NHP6

5 regional properties for Q8NHP6

Type Name Position InterPro Accession
conserved_site MoaA/NifB/PqqE, iron-sulphur binding, conserved site 73 - 84 IPR000385
domain Molybdopterin cofactor biosynthesis C (MoaC) domain 490 - 625 IPR002820
domain Elp3/MiaA/NifB-like, radical SAM core domain 67 - 270 IPR006638
domain Radical SAM 56 - 380 IPR007197
domain Molybdenum cofactor biosynthesis protein A-like, twitch domain 239 - 373 IPR010505

Functions

Description
EC Number
Subcellular Localization
  • Endoplasmic reticulum membrane ; Single-pass type IV membrane protein
  • Localization to contact sites involving the endoplasmic reticulum and several organelles is regulated by interaction with proteins containing FFAT motif (PubMed:29858488)
  • Dynamically distributes between specific subdomains of the endoplasmic reticulum (ER): ER membranes in contact with lipid droplets (LDs) and the remainder of the ER (PubMed:35389430)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
endomembrane system A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
endoplasmic reticulum-endosome membrane contact site A contact site between the endoplasmic reticulum membrane and the endosome membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
organelle membrane contact site A zone of apposition between the membranes of an organelle with another membrane, either another membrane of the same organelle, a membrane of another organelle, or the plasma membrane. Membrane contact sites (MCSs) are structured by bridging complexes. They are specialized for communication, including the efficient traffic of small molecules such as Ca2+ ions and lipids, as well as enzyme-substrate interactions.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
specific granule membrane The lipid bilayer surrounding a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

3 GO annotations of biological process

Name Definition
chemotaxis The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
positive regulation of monocyte chemotaxis Any process that increases the frequency, rate, or extent of monocyte chemotaxis.
positive regulation of neutrophil chemotaxis Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAENHAQNKA KLISETRRRF EAEYVTDKSD KYDARDVERL QQDDNWVESY LSWRHNIVDE
70 80 90 100 110 120
TLKMLDESFQ WRKEISVNDL NESSIPRWLL EIGVIYLHGY DKEGNKLFWI RVKYHVKDQK
130 140 150 160 170 180
TILDKKKLIA FWLERYAKRE NGKPVTVMFD LSETGINSID MDFVRFIINC FKVYYPKYLS
190 200 210 220 230 240
KIVIFDMPWL MNAAFKIVKT WLGPEAVSLL KFTSKNEVQD YVSVEYLPPH MGGTDPFKYS
250 260 270 280 290 300
YPPLVDDDFQ TPLCENGPIT SEDETSSKED IESDGKETLE TISNEEQTPL LKKINPTEST
310 320 330 340 350 360
SKAEENEKVD SKVKAFKKPL SVFKGPLLHI SPAEELYFGS TESGEKKTLI VLTNVTKNIV
370 380 390 400 410 420
AFKVRTTAPE KYRVKPSNSS CDPGASVDIV VSPHGGLTVS AQDRFLIMAA EMEQSSGTGP
430 440 450 460 470 480
AELTQFWKEV PRNKVMEHRL RCHTVESSKP NTLTLKDNAF NMSDKTSEDI CLQLSRLLES
490 500 510
NRKLEDQVQR CIWFQQLLLS LTMLLLAFVT SFFYLLYS